Drug pipeline updates
Drug Pipeline Quarterly Update: September 2020
Drugs in review, drugs with expiring patents, generic availability and more.
September 30, 2020
These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
September 2020 Quarterly Traditional Pipeline Update
September 2020 Quarterly Specialty Pipeline Update
Related research
Drug pipeline updates
October 14, 2021
November 2021 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…
Drug pipeline updates
September 30, 2021
Drug Pipeline Quarterly Update: September 2021
These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status…
Drug pipeline updates
September 12, 2021
October 2021 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…